Ardelyx, Inc.
USD5.23
-0.32 (-5.77%)
CEO
Michael G. Raab
IPO Date
2014-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.61
Prev. Close
$5.55
Day Low
$5.08
Day High
$5.62
52W Low
$3.74
52W High
$8.40
Market Cap
$1.29B
Volume
8.98M
| -30.5 |
| 31 Dec 2023 | FY | 85.7% | -53.1% | -39.6% | -22.2% | 0.34 | 4.88 | -20.6 |
| 31 Dec 2022 | FY | 92.1% | -128.9% | -68.3% | -35.4% | 0.37 | 2.34 | -6.7 |
| 31 Dec 2021 | FY | 90.1% | -1566.5% | -191.4% | -105.5% | 0.55 | 2.53 | -0.7 |
| 31 Dec 2020 | FY | 98.1% | -1245.7% | -74.8% | -46.8% | 0.44 | 6.87 | -1.5 |
| 31 Dec 2019 | FY | 88.6% | -1797.8% | -50.9% | -36.5% | 0.31 | 11.36 | -1.3 |
| 31 Dec 2018 | FY | 82.1% | -3502.0% | -78.8% | -49.8% | 0.42 | 10.02 | -0.3 |
| 31 Dec 2017 | FY | 80.0% | -153.2% | -46.2% | -40.7% | 0.00 | 8.39 | -1.2 |
| 31 Dec 2016 | FY | 94.6% | -467.8% | -58.2% | -52.7% | 0.00 | 10.62 | -1.3 |
| -872.4 |
| 30 Sept 2025 | Q3 | 95.6% | -0.9% | -0.6% | -0.2% | 1.35 | 4.41 | -343.9 |
| 30 Jun 2025 | Q2 | 86.7% | -19.5% | -13.7% | -4.1% | 1.48 | 4.30 | -12.3 |
| 31 Mar 2025 | Q1 | 82.6% | -55.5% | -28.2% | -10.0% | 1.06 | 4.12 | -7.1 |
| 31 Dec 2024 | Q4 | 84.3% | 4.0% | 2.7% | 1.1% | 0.89 | 4.58 | 64.8 |
| 30 Sept 2024 | Q3 | 84.0% | -0.8% | -0.5% | -0.2% | 0.66 | 4.03 | -502.3 |
| 30 Jun 2024 | Q2 | 86.3% | -22.5% | -11.2% | -4.8% | 0.71 | 4.21 | -27.0 |
| 31 Mar 2024 | Q1 | 83.6% | -57.6% | -17.6% | -7.7% | 0.70 | 4.53 | -16.3 |
| 31 Dec 2023 | Q4 | 85.2% | -83.8% | -17.3% | -9.7% | 0.34 | 4.88 | -12.5 |